Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.

MLA

Lumry, William R., et al. “Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.” The Journal of Allergy and Clinical Immunology. In Practice, vol. 6, no. 5, Sept. 2018, p. 1733. EBSCOhost, https://doi.org/10.1016/j.jaip.2017.12.039.

APA

Lumry, W. R., Craig, T., Zuraw, B., Longhurst, H., Baker, J., Li, H. H., Bernstein, J. A., Anderson, J., Riedl, M. A., Manning, M. E., Keith, P. K., Levy, D. S., Caballero, T., Banerji, A., Gower, R. G., Farkas, H., Lawo, J.-P., Pragst, I., Machnig, T., & Watson, D. J. (2018). Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. The Journal of Allergy and Clinical Immunology. In Practice, 6(5), 1733. https://doi.org/10.1016/j.jaip.2017.12.039

Chicago

Lumry, William R, Timothy Craig, Bruce Zuraw, Hilary Longhurst, James Baker, H Henry Li, Jonathan A Bernstein, et al. 2018. “Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.” The Journal of Allergy and Clinical Immunology. In Practice 6 (5): 1733. doi:10.1016/j.jaip.2017.12.039.